ABSTRACT
BACKGROUND: Fluid management practices during and after liver transplantation vary widely among centers despite better understanding of the pathophysiology of end-stage liver disease and of the effects of commonly used fluids. This reflects a lack of high quality trials in this setting, but also provides a rationale for both systematic review of all relevant studies in liver recipients and evaluation of new evidence from closely related domains, including hepatology, non-transplant abdominal surgery, and critical care. OBJECTIVES: To develop evidence-based recommendations for perioperative fluid management to optimize immediate and short-term outcomes following liver transplantation. DATA SOURCES: Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central. METHODS: Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Studies included those evaluating the following postoperative outcomes: acute kidney injury, respiratory complications, operative blood loss/red cell units required, and intensive care length of stay. PROSPERO protocol ID: CRD42021241392 RESULTS: Following expert panel review, 18 of 1624 screened studies met eligibility criteria for inclusion in the final quantitative synthesis. These included six single center RCTs, 11 single center observational studies, and one observational study comparing centers with different fluid management techniques. Definitions of interventions and outcomes varied between studies. Recommendations are therefore based substantially on expert opinion and evidence from other clinical settings. CONCLUSIONS: A moderately restrictive or "replacement only" fluid regime is recommended, especially during the dissection phase of the transplant procedure. Sustained hypervolemia, based on absence of fluid responsiveness, elevated filling pressures and/or echocardiographic findings, should be avoided (Quality of Evidence: Moderate | Grade of Recommendation: Weak for restrictive fluid regime. Strong for avoidance of hypervolemia). Mean Arterial Pressure (MAP) should be maintained at >60-65 mmHg in all cases (Quality of Evidence: Low | Grade of Recommendation: Strong). There is insufficient evidence in this population to support preferential use of any specific colloid or crystalloid for routine volume replacement. However, we recommend against the use of 130/.4 HES given the high incidence of AKI in this population.
Subject(s)
Acute Kidney Injury , Liver Transplantation , Adult , Humans , Living Donors , Fluid Therapy , Critical Care , Observational Studies as TopicABSTRACT
Liver transplantation (LT) in patients with portopulmonary hypertension (PoPH) has historically resulted in unpredictable and often poor outcomes. The United Kingdom experience for the period 1992-2012 is reported in this article. A retrospective analysis of patients, preoperatively fulfilling the PoPH European Respiratory Society Task Force on Pulmonary-Hepatic Vascular Disorders diagnostic criteria was conducted across all UK LT centers. Data collection included comorbidities, use of preoperative and postoperative pharmacotherapy, patient survival, and cause of death. To enable survival stratification, PoPH was classified as mild, moderate, or severe based on mean pulmonary pressure of <35 mm Hg, 35-49 mm Hg, and ≥50 mm Hg, respectively. Of 127 patients reported to have PoPH, just 28 fulfilled the diagnostic criteria (14 mild, 9 moderate, 5 severe). Twenty (71.4%) patients were male with median age and Model for End-Stage Liver Disease of 50 years (range, 23-62 years) and 18 (range, 6-43), respectively. Twelve (42.9%) patients died within 5 years of LT. The majority of deaths (10 of 12; 83%) occurred within the first 6 months after LT, aetiologies of which included right heart failure (n = 3), progressive PoPH (n = 2), and sepsis (n = 2). Of those receiving preoperative pharmacotherapy (n = 8), 5 are currently alive and were classified as mild to moderate PoPH. Both severe PoPH patients optimized preoperatively with pharmacotherapy died within a year of LT. Development of effective vasodilatory therapies in the setting of pulmonary arterial hypertension has led to a dramatic improvement in patient survival. The available data indicate that in this era of pharmacotherapy, PoPH in isolation no longer represents a valid consideration to transplant. Liver Transplantation 22 1637-1642 2016 AASLD.
Subject(s)
End Stage Liver Disease/complications , Hypertension, Portal/surgery , Hypertension, Pulmonary/surgery , Liver Transplantation/adverse effects , Vasodilator Agents/therapeutic use , Adult , End Stage Liver Disease/surgery , Female , Heart Failure/etiology , Heart Failure/mortality , Humans , Hypertension, Portal/drug therapy , Hypertension, Portal/etiology , Hypertension, Portal/mortality , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/mortality , Liver Transplantation/mortality , Liver Transplantation/standards , Male , Middle Aged , Practice Guidelines as Topic , Pulmonary Wedge Pressure , Retrospective Studies , Sepsis/etiology , Sepsis/mortality , Survival Rate , Treatment Outcome , United Kingdom/epidemiology , Young AdultABSTRACT
Ischemia/reperfusion injury (IRI) that develops after liver implantation may prejudice long-term graft survival, but it remains poorly understood. Here we correlate the severity of IRIs that were determined by histological grading of time-zero biopsies sampled after graft revascularization with patient and graft outcomes. Time-zero biopsies of 476 liver transplants performed at our center between 2000 and 2010 were graded as follows: nil (10.5%), mild (58.8%), moderate (26.1%), and severe (4.6%). Severe IRI was associated with donor age, donation after circulatory death, prolonged cold ischemia time, and liver steatosis, but it was also associated with increased rates of primary nonfunction (9.1%) and retransplantation within 90 days (22.7%). Longer term outcomes in the severe IRI group were also poor, with 1-year graft and patient survival rates of only 55% and 68%, respectively (cf. 90% and 93% for the remainder). Severe IRI on the time-zero biopsy was, in a multivariate analysis, an independent determinant of 1-year graft survival and was a better predictor of 1-year graft loss than liver steatosis, early graft dysfunction syndrome, and high first-week alanine aminotransferase with a positive predictive value of 45%. Time-zero biopsies predict adverse clinical outcomes after liver transplantation, and severe IRI upon biopsy signals the likely need for early retransplantation.
Subject(s)
Liver Transplantation/adverse effects , Reperfusion Injury/pathology , Adult , Age Factors , Aged , Alanine Transaminase/blood , Allografts , Biomarkers/blood , Biopsy , Cold Ischemia/adverse effects , Female , Graft Survival , Humans , Kaplan-Meier Estimate , Liver Transplantation/mortality , Logistic Models , Male , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Proportional Hazards Models , Reperfusion Injury/blood , Reperfusion Injury/etiology , Reperfusion Injury/mortality , Retrospective Studies , Risk Factors , Severity of Illness Index , Time Factors , Tissue Donors , Treatment Outcome , Young AdultSubject(s)
Liver Transplantation , Operative Blood Salvage , Sickle Cell Trait , Humans , Male , Young AdultABSTRACT
Marked dysnatremia is associated with increased mortality in patients admitted to intensive care. However, new evidence suggests that even mild deviations from normal and simple variability of sodium values may also be significant. Should these findings prompt clinicians to re-evaluate the approach to fluid management in this setting? Sodium disorders, on one hand, are known to result from overzealous administration or restriction of free water or sodium ions. However, they are also associated with a range of co-morbidities and drug treatments that alter water loss and sodium handling in the nephron independently of prescribed fluid regimens. Moreover, powerful neuroendocrine and inflammatory responses to surgery, trauma and other acute illness may induce or intensify such changes, altering the response to administered fluids. These observations suggest that both patient and treatment variables contribute, but the extent to which sodium disturbances are preventable and whether prevention improves outcome are unknown. Dysnatremia certainly reflects underlying systemic disorders, but how important is fluid management as a cause, and does it contribute independently to poorer outcomes through osmotic or other mechanisms? Although total fluid volume and doses of potassium and glucose are regularly adjusted in critically ill patients, sodium is usually delivered at standard concentrations as long as serum values lie within an acceptable range. It may be prudent to pay closer attention to these values, especially when abnormal, when fluctuating or when an adverse trend is present. More frequent measurements of sodium in blood, urine and drainage fluids, and appropriate adjustment of the sodium content of prescribed fluids, may be indicated. Until more light can be shed on the pathophysiology of dysnatremia in the critically ill, we should assume that better control of plasma sodium levels may yield better outcomes.
Subject(s)
Attention , Hypernatremia/blood , Hypernatremia/diagnosis , Hyponatremia/blood , Hyponatremia/diagnosis , Sodium/blood , Female , Humans , MaleABSTRACT
While there is evidence for an acceleration in global mean sea level (MSL) since the 1960s, its detection at local levels has been hampered by the considerable influence of natural variability on the rate of MSL change. Here we report a MSL acceleration in tide gauge records along the U.S. Southeast and Gulf coasts that has led to rates (>10 mm yr-1 since 2010) that are unprecedented in at least 120 years. We show that this acceleration is primarily induced by an ocean dynamic signal exceeding the externally forced response from historical climate model simulations. However, when the simulated forced response is removed from observations, the residuals are neither historically unprecedented nor inconsistent with internal variability in simulations. A large fraction of the residuals is consistent with wind driven Rossby waves in the tropical North Atlantic. This indicates that this ongoing acceleration represents the compounding effects of external forcing and internal climate variability.
ABSTRACT
Investigators at a single institution have shown that the organization of the anesthesia team influences patient outcomes after liver transplant surgery. Little is known about how liver transplant anesthesiologists are organized to deliver care throughout the United States. Therefore, we collected quantitative survey data from adult liver transplant programs in good standing with national governing agencies so that we could describe team structure and duties. Information was collected from 2 surveys in a series of quantitative surveys conducted by the Liver Transplant Anesthesia Consortium. All data related to duties, criteria for team membership, interactions/communication with the multidisciplinary team, and service availability were collected and summarized. Thirty-four of 119 registered transplant centers were excluded (21 pediatric centers and 13 centers not certified by national governing agencies). Private practice sites (26) were later excluded because of a poor response rate. There were minimal changes in the compositions of the programs between the 2 surveys. All academic programs had distinct liver transplant anesthesia teams. Most had set criteria for membership and protocols outlining the preoperative evaluation, attended selection committees, and were always available for transplant surgery. Fewer were involved in postoperative care or were available for patients needing subsequent surgery. Most trends were associated with the center volume. In conclusion, some of the variance in team structure and responsibilities is probably related to resources available at the site of practice. However, similarities in specific duties across all teams suggest some degree of self-initiated specialization.
Subject(s)
Academic Medical Centers/statistics & numerical data , Anesthesia, General/statistics & numerical data , Anesthesiology/statistics & numerical data , Health Care Surveys , Liver Transplantation/statistics & numerical data , Perioperative Care/statistics & numerical data , Adult , Health Services Accessibility/statistics & numerical data , Humans , Intensive Care Units/statistics & numerical data , Medical Staff, Hospital/statistics & numerical data , Registries/statistics & numerical data , United States/epidemiology , WorkforceABSTRACT
Although liver transplantation (LT) is a highly effective treatment, it has been considered too costly for publicly funded health systems in many countries with low to medium average incomes. However, with economic growth and improving results, some governments are reconsidering this position. Cost-effectiveness data for LT are limited, especially in perioperative care, and the techniques and costs vary widely between centers without overt differences in outcomes. Anesthesiologists working in new programs find it difficult to determine which modalities are essential, which are needed only in exceptional circumstances, and which may be omitted without effects on outcomes. We investigated key elements of preoperative evaluations, intraoperative management, and early postoperative care that might significantly affect costs in order to develop a best-value approach for new programs in resource-limited health systems. We identified all modalities of care commonly used in anesthesia and perioperative care for adult LT along with their costs. Those considered to be universally accepted as minimum requirements for safe care were excluded from the analysis, and so were those considered to be safe and low-cost, even when evidence of efficacy was lacking. The remaining items were, therefore, those with uncertain or context-restricted value and significant costs. A systematic review of the published evidence, practice surveys, and institutional guidelines was performed, and the evidence was graded and summarized. With respect to costs and benefits, each modality was then cited as strongly recommended, recommended or optional, or no recommendation was made because of insufficient evidence. Sixteen modalities, which included preoperative cardiovascular imaging, venovenous bypass, pulmonary artery catheterization, high-flow fluid warming devices, drug therapies for hemostasis, albumin, cell salvage, anesthetic drugs, personnel (staffing) requirements, and early extubation, were assessed. Only high-flow fluid warming was strongly recommended. The recommended modalities included preoperative echocardiography, cell salvage, tranexamic acid and early extubation. Six others were rated optional, and there was insufficient evidence for 5 modalities. We conclude that some costly techniques and treatments can be omitted without adverse effects on outcomes.
Subject(s)
Gross Domestic Product/statistics & numerical data , Liver Transplantation/economics , Models, Econometric , National Health Programs/economics , Perioperative Care/economics , Anesthesia/economics , Anesthesia/standards , Anesthesia/statistics & numerical data , Blood Loss, Surgical/prevention & control , Blood Loss, Surgical/statistics & numerical data , Cost-Benefit Analysis , Global Health , Health Care Costs/statistics & numerical data , Humans , Hypertension, Pulmonary/economics , Hypertension, Pulmonary/epidemiology , Liver Transplantation/standards , Liver Transplantation/statistics & numerical data , Monitoring, Physiologic/economics , Monitoring, Physiologic/standards , Monitoring, Physiologic/statistics & numerical data , Myocardial Ischemia/economics , Myocardial Ischemia/epidemiology , National Health Programs/standards , National Health Programs/statistics & numerical data , Perioperative Care/standards , Perioperative Care/statistics & numerical data , Quality of Health Care/economics , Quality of Health Care/statistics & numerical dataABSTRACT
Crassostrea oysters are protandrous hermaphrodites. Sex is thought to be determined by a single gene with a dominant male allele M and a recessive protandrous allele F, such that FF animals are protandrous and MF animals are permanent males. We investigate the possibility that a reduction in generation time, brought about for example by disease, might jeopardize retention of the M allele. Simulations show that MF males have a significantly lessened lifetime fecundity when generation time declines. The allele frequency of the M allele declines and eventually the M allele is lost. The probability of loss is modulated by population abundance. As abundance increases, the probability of M allele loss declines. Simulations suggest that stabilization of the female-to-male ratio when generation time is long is the dominant function of the M allele. As generation time shortens, the raison d'être for the M allele also fades as mortality usurps the stabilizing role. Disease and exploitation have shortened oyster generation time: one consequence may be to jeopardize retention of the M allele. Two alternative genetic bases for protandry also provide stable sex ratios when generation time is long; an F-dominant protandric allele and protandry restricted to the MF heterozygote. In both cases, simulations show that FF individuals become rare in the population at high abundance and/or long generation time. Protandry restricted to the MF heterozygote maintains sex ratio stability over a wider range of generation times and abundances than the alternatives, suggesting that sex determination based on a male-dominant allele (MM/MF) may not be the optimal solution to the genetic basis for protandry in Crassostrea.
Subject(s)
Models, Genetic , Ostreidae/genetics , Sex Determination Processes/genetics , Animals , Female , Gene Frequency , Male , Population Density , Population Dynamics , Sex RatioABSTRACT
A time-dependent model of Margalefidinium polykrikoides, a mixotrophic dinoflagellate, cell growth was implemented to assess controls on blooms in the Lafayette River, a shallow, tidal sub-tributary of the lower Chesapeake Bay. Simulated cell growth included autotrophic and heterotrophic contributions. Autotrophic cell growth with no nutrient limitation resulted in a bloom but produced chlorophyll concentrations that were 45% less than observed bloom concentrations (~80 mg Chl m-3 vs. 145 mg Chl m-3) and a bloom progression that did not match observations. Excystment (cyst germination) was important for bloom initiation, but did not influence the development of algal biomass or bloom duration. Encystment (cyst formation) resulted in small losses of biomass throughout the bloom but similarly, did not influence M. polykrikoides cell density or the duration of blooms. In contrast, the degree of heterotrophy significantly impacted cell densities achieved and bloom duration. When heterotrophy contributed a constant 30% to cell growth, and dissolved inorganic nitrogen was not limiting, simulated chlorophyll concentrations were within those observed during blooms (maximum ~140 mg Chl m-3). However, nitrogen limitation quenched the maximum chlorophyll concentration by a factor of three. Specifying heterotrophy as an increasing function of nutrient limitation, allowing it to contribute up to 50% and 70% of total growth, resulted in simulated maximum chlorophyll concentrations of 90 mg Chl m-3 and 180 mg Chl m-3, respectively. This suggested that blooms of M. polykrikoides in the Lafayette River are fortified and maintained by substantial heterotrophic nutritional inputs. The timing and progression of the simulated bloom was controlled by the temperature range, 23 °C to 28 °C, that supports M. polykrikoides growth. Temperature increases of 0.5 °C and 1.0 °C, consistent with current warming trends in the lower Chesapeake Bay due to climate change, shifted the timing of bloom initiation to be earlier and extended the duration of blooms; maximum bloom magnitude was reduced by 50% and 65%, respectively. Warming by 5 °C suppressed the summer bloom. The simulations suggested that the timing of M. polykrikoides blooms in the Lafayette River is controlled by temperature and the bloom magnitude is determined by trade-offs between the severity of nutrient limitation and the relative contribution of mixotrophy to cell growth.
Subject(s)
Dinoflagellida , Harmful Algal Bloom , Bays , Rivers , TemperatureABSTRACT
Aprotinin is an antifibrinolytic drug that reduces blood loss during orthotopic liver transplantation (OLT). Case reports have suggested that aprotinin may be associated with an increased risk of thromboembolic complications. Recent studies in cardiac surgery also have suggested a higher risk of renal failure and postoperative mortality. Despite these concerns, no large-scale safety assessment has been performed in OLT. In a retrospective observational study involving 1492 liver transplants, we studied the occurrence of postoperative thromboembolic or thrombotic events and mortality in patients who received aprotinin (n = 907) and patients who did not (n = 585). The overall incidence of hepatic artery thrombosis and central venous complications (pulmonary embolism or inferior vena cava thrombosis) was 3.2% and 0.9%, respectively. In propensity score-adjusted analyses (C-index = 0.79), aprotinin was not associated with an increased risk of hepatic artery thrombosis [odds ratio (OR) = 1.00, 95% confidence interval (CI) = 0.50-2.01, P = 0.86]. Although central venous complications were found more frequently in patients receiving aprotinin, the difference was not statistically significant (OR = 2.95, 95% CI = 0.54-16.23, P = 0.32). In addition, no significant differences were found in 1-year mortality (OR = 1.21, 95% CI = 0.86-1.71, P = 0.32). In conclusion, this study did not demonstrate an increased risk of thrombotic complications or mortality when aprotinin is used during OLT.
Subject(s)
Aprotinin/pharmacology , Liver Transplantation/methods , Thrombosis/etiology , Adult , Female , Hemostatics/pharmacology , Hepatic Artery/pathology , Humans , Liver Failure/complications , Liver Failure/therapy , Male , Middle Aged , Odds Ratio , Retrospective Studies , Risk , Thrombosis/complications , Treatment OutcomeABSTRACT
Transcranial Doppler (TCD) ultrasonography allows continuous non-invasive monitoring of cerebral blood flow velocity in a variety of clinical conditions. Recently, signal processing of TCD signals has provided several comprehensive parameters for the assessment of cerebral haemodynamics. In this work, we applied a TCD multimodal approach in patients with acute liver failure undergoing orthotopic liver transplant (OLT) to assess the clinical feasibility of using TCD for cerebral haemodynamics assessment in this setting. We retrospectively studied six patients undergoing OLT with continuous monitoring of arterial blood pressure and blood flow velocity in the middle cerebral artery. The main cerebral haemodynamic parameters assessed were non-invasive intracranial pressure, cerebral perfusion pressure, cerebral autoregulation, pulsatility index, critical closing pressure and diastolic closing margin. TCD monitoring revealed marked alterations of these parameters in the OLT setting, which could provide relevant clinical information when there is imminent risk of neurologic impairment.
Subject(s)
Cerebrovascular Circulation/physiology , Intracranial Pressure/physiology , Liver Transplantation , Middle Cerebral Artery/diagnostic imaging , Monitoring, Intraoperative/methods , Ultrasonography, Doppler, Transcranial/methods , Aged , Female , Homeostasis , Humans , Male , Middle Aged , Retrospective StudiesABSTRACT
Nonalcoholic steatohepatitis (NASH)-related cirrhosis has become one of the most common indications for liver transplantation (LT), particularly in candidates older than 65 years. Typically, NASH candidates have concurrent obesity, metabolic, and cardiovascular risks, which directly impact patient evaluation and selection, waitlist morbidity and mortality, and eventually posttransplant outcomes. The purpose of these guidelines is to highlight specific features commonly observed in NASH candidates and strategies to optimize pretransplant evaluation and waitlist survival. More specifically, the working group addressed the following clinically relevant questions providing recommendations based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system supported by rigorous systematic reviews and consensus: (1) Is the outcome after LT similar to that of other etiologies of liver disease? (2) Is the natural history of NASH-related cirrhosis different from other etiologies of end-stage liver disease? (3) How should cardiovascular risk be assessed in the candidate for LT? Should the assessment differ from that done in other etiologies? (4) How should comorbidities (hypertension, diabetes, dyslipidemia, obesity, renal dysfunction, etc.) be treated in the candidate for LT? Should treatment and monitoring of these comorbidities differ from that applied in other etiologies? (5) What are the therapeutic strategies recommended to improve the cardiovascular and nutritional status of a NASH patient in the waiting list for LT? (6) Is there any circumstance where obesity should contraindicate LT? (7) What is the optimal time for bariatric surgery: before, during, or after LT? (8) How relevant is donor steatosis for LT in NASH patients?
Subject(s)
Bariatric Surgery/standards , Consensus Development Conferences as Topic , End Stage Liver Disease/surgery , Liver Cirrhosis/surgery , Non-alcoholic Fatty Liver Disease/surgery , Cardiovascular Diseases/epidemiology , Comorbidity , Consensus , End Stage Liver Disease/pathology , Humans , Liver Cirrhosis/pathology , Liver Transplantation , Non-alcoholic Fatty Liver Disease/epidemiology , Non-alcoholic Fatty Liver Disease/pathology , Obesity/epidemiology , Obesity/surgery , Time Factors , Tissue and Organ Procurement/standards , Treatment Outcome , Waiting Lists/mortalityABSTRACT
PURPOSE OF REVIEW: The present review describes new trends and ongoing controversies in the anesthetic care of liver transplant recipients. RECENT FINDINGS: Recent studies have improved our knowledge of conditions increasing perioperative risk, such as portopulmonary hypertension and renal failure. Improved surgical and anesthetic management has reduced intraoperative blood loss, as more studies identify an independent association between blood transfusion and poor outcome. New concepts in the coagulopathy of liver failure are emerging, with clear implications for clinical practice, including greater awareness of the risks of intraoperative thromboembolism. Less invasive intraoperative hemodynamic monitoring has been advocated, as has wider use of transoesophageal echocardiography. Early extubation is becoming more routinized. SUMMARY: Anesthetic management still varies widely between liver transplant centers with little data to indicate best practice. Future research should focus on fluid replacement, prevention and treatment of coagulopathy, care of the acutely ill patient and the safety and benefits of early extubation.
Subject(s)
Anesthesia, General/methods , Blood Coagulation Disorders/prevention & control , Liver Failure/prevention & control , Liver Transplantation/standards , Preoperative Care/methods , Anesthesia, General/standards , Anesthesia, General/trends , Blood Transfusion/methods , Hemodynamics/drug effects , Hemodynamics/physiology , Humans , Hyperkalemia/etiology , Hyperkalemia/prevention & control , Monitoring, Intraoperative/methods , Monitoring, Intraoperative/standardsABSTRACT
BACKGROUND: A program of normothermic ex situ liver perfusion (NESLiP) was developed to facilitate better assessment and use of marginal livers, while minimizing cold ischemia. METHODS: Declined marginal livers and those offered for research were evaluated. Normothermic ex situ liver perfusion was performed using an erythrocyte-based perfusate. Viability was assessed with reference to biochemical changes in the perfusate. RESULTS: Twelve livers (9 donation after circulatory death [DCD] and 3 from brain-dead donors), median Donor Risk Index 2.15, were subjected to NESLiP for a median 284 minutes (range, 122-530 minutes) after an initial cold storage period of 427 minutes (range, 222-877 minutes). The first 6 livers were perfused at high perfusate oxygen tensions, and the subsequent 6 at near-physiologic oxygen tensions. After transplantation, 5 of the first 6 recipients developed postreperfusion syndrome and 4 had sustained vasoplegia; 1 recipient experienced primary nonfunction in conjunction with a difficult explant. The subsequent 6 liver transplants, with livers perfused at lower oxygen tensions, reperfused uneventfully. Three DCD liver recipients developed cholangiopathy, and this was associated with an inability to produce an alkali bile during NESLiP. CONCLUSIONS: Normothermic ex situ liver perfusion enabled assessment and transplantation of 12 livers that may otherwise not have been used. Avoidance of hyperoxia during perfusion may prevent postreperfusion syndrome and vasoplegia, and monitoring biliary pH, rather than absolute bile production, may be important in determining the likelihood of posttransplant cholangiopathy. Normothermic ex situ liver perfusion has the potential to increase liver utilization, but more work is required to define factors predicting good outcomes.
Subject(s)
Donor Selection , Hyperoxia/etiology , Liver Transplantation/methods , Perfusion/methods , Postoperative Complications/etiology , Vasoplegia/etiology , Warm Ischemia/methods , Adult , Aged , Cold Ischemia , Follow-Up Studies , Humans , Hyperoxia/prevention & control , Middle Aged , Outcome Assessment, Health Care , Perfusion/adverse effects , Postoperative Complications/prevention & control , Vasoplegia/prevention & control , Warm Ischemia/adverse effectsSubject(s)
Organ Transplantation , Tissue Donors/supply & distribution , Anesthesia , Critical Care , Hepatectomy , Humans , Living Donors/supply & distribution , Organ Transplantation/adverse effects , Organ Transplantation/standards , Quality of Health Care/standards , Treatment Outcome , Waiting ListsABSTRACT
STUDY OBJECTIVE: To determine current practice patterns for patients receiving liver transplantation. DESIGN: International, web-based survey instrument. SETTING: Academic medical centers. MEASUREMENTS: Survey database responses to questions about liver transplant anesthesiology programs and current intraoperative anesthetic care and resource utilization were assessed. Descriptive statistics of intraoperative practices and resource utilization according to the size of the transplant program were recorded. MAIN RESULTS: Anesthetic management practices for liver transplantation varied across the academic centers. The use of cell salvage (Cell Saver®), transesophageal echocardiography, thrombelastography, and ultrasound guidance for catheter placement varies among institutions. CONCLUSION: Effective practices and more evidence-based intraoperative management have not yet been applied in many programs. Many facets of perioperative liver transplantation anesthesia care remain underexplored.
Subject(s)
Anesthesia/methods , Anesthesiology/methods , Liver Transplantation/methods , Monitoring, Intraoperative/methods , Perioperative Care/methods , Academic Medical Centers/statistics & numerical data , Evidence-Based Medicine , Health Care Surveys , Humans , Internet , Intraoperative Care/methods , United StatesABSTRACT
BACKGROUND: A regimen of fluid restriction, phlebotomy, vasopressors, and strict, protocol-guided product replacement has been associated with low blood product use during orthotopic liver transplantation. However, the physiologic basis of this strategy remains unclear. We hypothesized that a reduction of intravascular volume by phlebotomy would cause a decrease in portal venous pressure (PVP), which would be sustained during subsequent phenylephrine infusion, possibly explaining reduced bleeding. Because phenylephrine may increase central venous pressure (CVP), we questioned the validity of CVP as a correlate of cardiac filling in this context and compared it with other pulmonary artery catheter and transesophageal echocardiography-derived parameters. In particular, because optimal views for echocardiographic estimation of preload and stroke volume are not always applicable during liver transplantation, we evaluated the use of transmitral flow (TMF) early peak (E) velocity as a surrogate. METHODS: In study 1, the changes in directly measured PVP and CVP were recorded before and after phlebotomy and phenylephrine infusion in 10 patients near the end of the dissection phase of liver transplantation. In study 2, transesophageal echocardiography-derived TMF velocity in early diastole was measured in 20 patients, and the changes were compared with changes in CVP, pulmonary artery pressure (PAP), pulmonary capillary wedge pressure (PCWP), cardiac output (CO), and calculated systemic vascular resistance (SVR) at the following times: postinduction, postphlebotomy, preclamping of the inferior vena cava, during clamping, and postunclamping. RESULTS: Phlebotomy decreased PVP along with CO, PAP, PCWP, CVP, and TMF E velocity. Phenylephrine given after phlebotomy increased CVP, SVR, and arterial blood pressure but had no significant effect on CO, PAP, PCWP, or PVP. The change in TMF E velocity correlated well with the change in CO (Pearson correlation coefficient 95% confidence interval 0.738-0.917, P< or =0.015) but less well with the change in PAP (0.554-0.762, P< or =0.012) and PCWP (0.576-0.692, P< or =0.008). TMF E velocity did not correlate significantly with CVP or calculated SVR. CONCLUSION: Phlebotomy during the dissection phase of liver transplantation decreased PVP, which was unaffected when phenylephrine infusion was used to restore systemic arterial pressure. This may contribute to a decrease in operative blood loss. CVP often increased in response to phenylephrine infusion and did not seem to reflect cardiac filling. The changes in TMF E velocity correlated well with the changes in CO, PAP, and PCWP during liver transplantation but not with the changes in CVP.
Subject(s)
Blood Loss, Surgical/prevention & control , Hemodynamics/drug effects , Liver Transplantation/methods , Phenylephrine/administration & dosage , Phlebotomy , Portal Pressure/drug effects , Vasoconstrictor Agents/administration & dosage , Cardiac Output/drug effects , Catheterization, Swan-Ganz , Central Venous Pressure/drug effects , Echocardiography, Doppler, Color , Echocardiography, Transesophageal , Humans , Infusions, Intravenous , Liver Transplantation/adverse effects , Middle Aged , Mitral Valve/diagnostic imaging , Monitoring, Intraoperative/methods , Pilot Projects , Pulmonary Wedge Pressure/drug effects , Vascular Resistance/drug effectsABSTRACT
A hydrodynamic-oyster population model was developed to assess the effect of changes in freshwater inflow on oyster populations in Galveston Bay, Texas, USA. The population model includes the effects of environmental conditions, predators, and the oyster parasite, Perkinsus marinus, on oyster populations. The hydrodynamic model includes the effects of wind stress, river runoff, tides, and oceanic exchange on the circulation of the bay. Simulations were run for low, mean, and high freshwater inflow conditions under the present (1993) hydrology and predicted hydrologies for 2024 and 2049 that include both changes in total freshwater inflow and diversions of freshwater from one primary drainage basin to another. Freshwater diversion to supply the Houston metropolitan area is predicted to negatively impact oyster production in Galveston Bay. Fecundity and larval survivorship both decline. Mortality from Perkinsus marinus increases, but to a lesser extent. A larger negative impact in 2049 relative to 2024 originates from the larger drop in fecundity under that hydrology. Changes in recruitment and mortality, resulting in lowered oyster abundance, occur because the bay volume available for mixing freshwater input from the San Jacinto and Buffalo Bayou drainage basins that drain metropolitan Houston is small in comparison to the volume of Trinity Bay that presently receives the bulk of the bay's freshwater inflow. A smaller volume for mixing results in salinities that decline more rapidly and to a greater extent under conditions of high freshwater discharge.Thus, the decline in oyster abundance results from a disequilibrium between geography and salinity brought about by freshwater diversion. Although the bay hydrology shifts, available hard substrate does not. The simulations stress the fact that it is not just the well-appreciated reduction in freshwater inflow that can result in decreased oyster production. Changing the location of freshwater inflow can also significantly impact the bay environment, even if the total amount of freshwater inflow does not change.
Subject(s)
Models, Theoretical , Ostreidae , Water Movements , Water Supply , Animals , Female , Larva , Male , Mortality , Population Dynamics , Survival , Texas , WindABSTRACT
Although liver transplantation (LT) is a highly effective treatment, it has been considered too costly for publicly funded health systems in many countries with low to medium average incomes. However, with economic growth and improving results, some governments are reconsidering this position. Cost-effectiveness data for LT are limited, especially in perioperative care, and the techniques and costs vary widely between centers without overt differences in outcomes. Anesthesiologists working in new programs find it difficult to determine which modalities are essential, which are needed only in exceptional circumstances, and which may be omitted without effects on outcomes. We investigated key elements of preoperative evaluations, intraoperative management, and early postoperative care that might significantly affect costs in order to develop a best-value approach for new programs in resource-limited health systems. We identified all modalities of care commonly used in anesthesia and perioperative care for adult LT along with their costs. Those considered to be universally accepted as minimum requirements for safe care were excluded from the analysis, and so were those considered to be safe and low-cost, even when evidence of efficacy was lacking. The remaining items were, therefore, those with uncertain or context-restricted value and significant costs. A systematic review of the published evidence, practice surveys, and institutional guidelines was performed, and the evidence was graded and summarized. With respect to costs and benefits, each modality was then cited as strongly recommended, recommended or optional, or no recommendation was made because of insufficient evidence. Sixteen modalities, which included preoperative cardiovascular imaging, venovenous bypass, pulmonary artery catheterization, high-flow fluid warming devices, drug therapies for hemostasis, albumin, cell salvage, anesthetic drugs, personnel (staffing) requirements, and early extubation, were(AU)